Program areas at Damon Runyon Cancer Research Foundation
Fellowship awards: supports the training of the brightest postdoctoral scientists as they embark upon their Research careers. This funding enables them to be trained by established investigators in leading Research laboratories across the country, while independently conducting leading-edge science that will bring new understanding and cures for Cancer.
Rachleff innovation awards: supports the next generation of exceptionally creative thinkers with "high risk/high reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of Cancer, but lack sufficient preliminary data to obtain traditional funding.
Clinical investigator awards: supports early career physician-scientists conducting patient-oriented Research. the goal of this program is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient's bedside in search of breakthrough treatments.
Dale f. frey awards - awards are given to the most outstanding fellows completing their fellowship award, in the amount of $100,000 each, to accelerate their Research and careers.
the Damon runyon-sohn pediatric Cancer fellowship award seeks to rebuild the dwindling ranks of scientists committed to saving children from Cancer. It funds both basic laboratory Research and the translation of Research findings into new treatments for children and young adults.
Physician-scientist training awards - supports and encourages outstanding physicians to pursue Cancer Research careers by providing them with the opportunity for a protected Research training experience under the mentorship of a highly qualified and gifted mentor.
Quantitative biology awards - this award program is designed to encourage quantitative scientists (trained in fields such as mathematics, computer science, physics, engineering, and others) to pursue Research careers in computational biology under the joint mentorship of leaders in both computational science ("dry lab") and Cancer biology ("wet lab"). By investing in this area, Damon runyon will bring additional attention to the importance of these specially trained scientists for making meaningful progress in Cancer biology.